Monthly Archives: March 2019

KKR and Tivoli Capital to Develop New Co-Working Locations in France

KKR

France, 12 March 2019: KKR, a leading global investment firm, and Tivoli Capital, a specialist in real estate development in France and the creator of the iLOV’iT Worklabs co-working space, have signed an agreement for the development of a new generation of office buildings in France’s largest cities.

The co-working market in France is developing rapidly. The concept, launched in the United States over 15 years ago and now fully developed in London, Amsterdam, Frankfurt and Madrid, grew by 80% between 2016 and 2017 in France, according to JLL’s 2018 global market report. Entrepreneurialism is growing in France, driven by increases in project-based work, working remotely and the importance of work-life balance.

The new developments build on the success of iLOV’iT, the largest co-working center in Marseille, with a surface area of almost 3,700m2, private offices, shared spaces and meeting rooms with well-being services. Tivoli Capital aims to develop its platform in this market, following the agreement with KKR. The new generation of offices will focus on having a welcoming working environment and offering various services adapted to the needs of residents. It will offer an alternative solution to entrepreneurs who want flexible, ready-to-use offices without long-term commitment.

Guillaume Pellegrin, Founder of Tivoli Capital, said “From the beginning, we wanted to develop our presence in France. We are pleased to have signed an agreement with KKR, who will support us in all areas of our development. Our goal is to transform the market, putting human beings at the heart of our project to be able to offer the ideal workspace in the 2020s for entrepreneurs and companies, regardless of their size, in all major French cities.”

Mai-Lan de Marcilly, Director at KKR in the European Real Estate team, said “Guillaume and his team have real expertise in the acquisition and development of innovative real estate projects within France, with a unique approach to improving quality of life at work. With this agreement, our aim is to become a leader in the French professional co-working space.”

KKR’s investment was made through its Real Estate Partners Europe fund.

About KKR

KKR is a leading global investment firm that manages multiple alternative asset classes, including private equity, energy, infrastructure, real estate and credit, with strategic partners that manage hedge funds. KKR aims to generate attractive investment returns for its fund investors by following a patient and disciplined investment approach, employing world-class people, and driving growth and value creation with KKR portfolio companies. KKR invests its own capital alongside the capital it manages for fund investors and provides financing solutions and investment opportunities through its capital markets business. References to KKR’s investments may include the activities of its sponsored funds. For additional information about KKR & Co. Inc. (NYSE:KKR), please visit KKR’s website at www.kkr.com and on Twitter @KKR_Co.

About Tivoli Capital

Created by Guillaume Pellegrin in Marseille, TIVOLI CAPITAL offers a wide range of real estate and financial services for investors wishing to diversify into regional markets. With a recognized know-how, the company has valued more than 250,000 m2 since its origin, and managed nearly 500 million euros of real estate assets for the Caisse des Dépôts, CEPAC, Carlyle, COVIVIO, and Primonial. Tivoli also managed the property and the financial director of The Camp, the first European campus dedicated to emerging technologies and the city of tomorrow. More information on www.tivoli-capital.com.

Media contacts for KKR:

France
Adding Value Conseils
Olivier Blain: ob@addingvalueconseils.com / + 33 6 72 28 29 20
Florence Taieb: ft@addingvalueconseils.com / +33 6 71 90 40 57

UK & International
Alastair Elwen, Finsbury
Email: alastair.elwen@finsbury.com
Phone: +44(0)20 7251 3801

Media contacts for Tivoli Capital:
Eve Leporq
Tel: +33 6 62 46 84 82
Email: eve@votredircom.fr

Categories: News

Tags:

CSAM Announces Deal to Acquire Arcid AS

Priveq

The transaction further strengthens CSAM’s leadership in the Nordic niche eHealth market

OSLO, Norway (March 12th, 2018) –CSAM announced today that it has signed an agreement to acquire Arcid –a Norwegian eHealth company that focuses on information flow in the tele radiology domain.

Arcid provides eHealth solutions that improve workflows and simplify the interaction between healthcare professionals. Among the company’s best-known products are TRIS, a Radiology Information System;Arcidis, a teleradiology information solution;and HelseMail, a Software as Service (SaaS) communication platform that enables theencrypted transferof large, high volume, and sensitive patient information.

-The combination of CSAM and Arcid will create an innovative and comprehensive offering in the medical imaging and connected health markets, enabling us to better serve clinicians and patients, said Sverre Flatby, CSAM CEO. –Arcid has an impressive reputation for delivering efficiency, quality, and exceptional patient care with their niche software solutions, and we are pleased they have entrusted CSAM to carry on that tradition of excellence.

-I am confident that CSAM is the right home for Arcid’s team in this exciting growth period to come, said Kåre-Bjørn Kongsnes, business developer and majority shareholder of Arcid. –Integrating our highly competent team of people with CSAM, the leading Nordic niche player within eHealth, strengthens this viable and powerful position.

The acquisition of Arcid is consistent with CSAM’s strategy to pursue growth through a combination of strategic M&As and organic sales. The transaction is estimated to close before the end of the month.

-Arcid’s products are an important complement to CSAM’s software solutions in the medical imaging and connected healthcare domains, strengthening our leadership in these key market segments, said Flatby. -The mixture of our customers, code and competencies will allow us to provide even greater value to customers across both public and private healthcare organisations.

CSAM has been a leading provider of medical imaging and connected healthcare solutions in the Nordics for more than a decade.The company works closely with healthcare professionals and organisations to develop software solutions that deliver the highest value for their operations.

About CSAM

CSAM has established itself as a leading Nordic niche player in the specialised eHealth marketwith a unique blend of best-in-class innovative technology, and outstanding human skills. The company’s diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. CSAM’scommercialheadquarters are located in Oslo, Norway. In addition to the new offices in Tromsø, the companyalso has local offices in Stockholm, Karlstad, Gothenburg, Helsinki, Oulu, Tampere, and Warwickshire, as well as a wholly owned software engineering subsidiary in the Philippines.

A privately-owned company backed by strong financial partners, CSAM aspires to achieve continued growth both organically and through selected mergers and acquisitions. For more information, visit www.csamhealth.com.

For more information, please contact:

Sverre Flatby, CEOJennifer Goode, Communications Directorsverre.flatby@csamhealth.comjennifer.goode@csamhealth.com+47 9159 9159+1-705-760-0782Kåre-Bjørn Kongsnes, Business Developerkb@kongsnes.no+47 900 11 040

Categories: News

Tags:

Gilde Healthcare acquires healthcare food supplier Eetgemak from Value8

GIlde Healthcare

Gilde Healthcare’s investment allows Eetgemak to realize new growth plans, including expansion into Belgium

Utrecht and Frankfurt – Gilde Healthcare, the European specialist investor in healthcare, acquires a majority stake in Eetgemak from stock listed investment firm Value8. The acquisition is the first investment in Gilde Healthcare’s new €200 million private equity fund focused on the healthcare industry. Katwijk based Eetgemak is the market leader in chilled meals for Dutch healthcare institutions. With Gilde as a new investor, Eetgemak will further expand its market position by growing in both existing as well as new markets, like Belgium.

Doctors and dietitians increasingly recognize the importance of tasty, healthy food that meets the patient’s wishes in the healing process. At the same time, there is a constant pressure on healthcare institutions to work more efficiently and to provide better care with less staff. With an assortment of thousands of different chilled meals, Eetgemak offers hospitals, care institutions and people at home healthy meals at low prices. Moreover, through its scale and expertise, Eetgemak is able to cater to the many types of dietary needs of patients and residents in care institutions.

The investment in Eetgemak fits well in Gilde Healthcare’s new private equity fund: “We look for companies that contribute to the improvement of care. Moreover, we actively contribute to the development of our portfolio companies through our specific knowledge and experience in the healthcare industry. We are very excited about Eetgemak’s growth opportunities and look forward to a productive collaboration,” says Hugo de Bruin, partner at Gilde Healthcare.

“Gilde’s investment enables us to execute our growth strategy, not only in the Netherlands, but also across the border in Belgium. In addition to accelerating organic growth, we are also interested in new partnerships and potential acquisitions,” says Leo van der Krogt, CEO at Eetgemak.

About Eetgemak

Eetgemak prepares chilled meals for hospitals, home care organizations, care centers, nursing homes, expertise centers, service apartments, living communities, restaurants, caterers, schools and daycare centers. Professional chefs prepare a wide range of seasonal dishes with great pleasure every day. Our motto is ‘everyone joins for dinner’. Whether it’s preference, meal type, consistency or diet; taste and quality are always paramount. Everyone deserves a healthy, fresh and tasty meal. This is why every day we cook fresh and healthy meals with the best ingredients. https://www.eetgemak.nl

About Gilde Healthcare

Gilde Healthcare is a specialized European healthcare investor managing €1 billion across two fund strategies: private equity and venture & growth capital. Gilde Healthcare’s private equity fund invests in profitable European lower mid-market healthcare companies including healthcare providers, suppliers of medical products and service providers, with a primary focus on the Benelux and DACH regions. Gilde Healthcare’s venture & growth fund is focused on fast growing health tech and therapeutics companies based in Europe and North America. https://gildehealthcare.com

 

Media Contacts

Gilde Healthcare

Hugo de Bruin
Partner
Newtonlaan 91
3584BP Utrecht
The Netherlands
debruin@gildehealthcare.com
+31 (0)30 219 2565

Eetgemak

Leo van der Krogt
CEO
Taanderstraat 9a
2222 BG Katwijk
The Netherlands
leo@eetgemak.nl
+31 (0)71 408 4140

Categories: News

Tags:

New brand launches next generation payment solutions

ik-investment-partners

The well-known Nordic brands OpenSolution (Sw), KDR (No) and Finnpos (Fi) have joined forces under the new brand OPEN. “We wanted a brand that reflects our value proposition – delivering innovative and customized payment solutions, helping our customers to plan, perform and grow their businesses,” says CEO Mikael Hedlöf.

OPEN covers the entire value chain of payment solutions, making it a single point of contact for >13,000 customers throughout the Nordics and Baltics with 18,000 systems installed. In conjunction with the rebranding, OPEN will also launch the next generation of Point of Sale (POS) solutions to restaurants, convenience stores and the cruise ship segment.

“We know that an innovative payment solution can increase a company’s revenue by up to 30% as well as improve employee wellbeing in the workplace. With this in mind, we reinvented our POS experience to better suit the fast-paced business environment. We are proud to say that OPEN’s system is the market’s most complete cash register system with everything from hardware, payment solutions, reporting tools, integrations and support,” commented Mikael Hedlöf, CEO of OPEN.

Restaurant chain ‘The Barn’ is one of the clients who has tested OPEN’s new POS system.

“Having tested OPEN’s new POS offering, we are thoroughly impressed by its functionality and innovative features.  Our collaboration with OPEN helps us grow as a company,” said Marcus Martinsson, CEO at The Barn.

For more information, please contact:
Mikael Hedlöf, CEO
mikael.hedlof@openpos.tech
+46 (0)70-283 76 28

Categories: News

Tags:

Gilde Healthcare leads EUR 20M Series A financing round of Calypso Biotech

GIlde Healthcare

Utrecht, The Netherlands and Boston, US – Calypso Biotech (Amsterdam, The Netherlands), an emerging leader in the development of therapeutic antibodies for autoimmune diseases, announces today the closing of a €20M Series A financing led by Gilde Healthcare and Inkef Capital. They are joined by Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and the company’s founding investor M Ventures. Further, Calypso Biotech has become Resident Company at Johnson & Johnson Innovation JLABS at Beerse in Belgium (JLABS@BE). Arthur Franken from Gilde Healthcare will join the Board of Directors.

The proceeds from this financing round will support the development of Calypso Biotech’s best-in class anti-Interleukin-15 (IL-15) antibody CALY-002 up to First-in-Patient studies in several autoimmune indications. IL-15 is an immune checkpoint cytokine that controls inflammation as well as multiple tissue-resident immune cells and recently attracted much attention in the immune-oncology space. Especially, IL-15 is being recognized as a key factor in the survival of tissue resident memory T cells, a population of immune cells involved in disease maintenance and recurrence. Calypso Biotech scientists believe that targeting tissue resident memory T cells offers significant advantages over traditional cytokine interventional approaches and could provide for unprecedented disease-modifying effects.

Calypso Biotech has chosen to develop CALY-002 in Eosinophilic Esophagitis (EoE) as well as in other undisclosed auto-immune indications. EoE is a severe and debilitating immune-related chronic disease of the esophagus that is the second leading cause of dysphagia (difficulty in swallowing) in adults. EoE has emerged as a frequent and significant cause of upper gastrointestinal morbidity particularly associated with important quality of life impairment and significant financial healthcare burden. CALY-002 has secured Orphan Drug Designation status from the European Medicines and Food & Drug Administration agencies for EoE.

Calypso Biotech is also announcing major strengthening of its team. Bernard Coulie, current president and CEO of Pliant Therapeutics, will be appointed as independent Chairman of the Board. Together with Alexandre LeBeaut, Executive Vice-President and CSO of Ipsen and current independent Director of Calypso Biotech, they will contribute to develop its strategic vision and corporate success. Prof. Bart Lambrecht, from the VIB-UGent Center for Inflammation Research (Belgium), a leading translational immunology expert, will join Calypso Biotech Scientific Advisory Board. Dr. Josephin-Beate Holz (ex Ablynx NV), Dr Greg Elson (ex Glenmark, Novimmune), Dr Susana Salgado (ex Novimmune), and Duc Tran (ex Prexton Therepeutics, Preglem, Pfizer) will join as medical, manufacturing, non-clinical development and strategic planning advisors, respectively.

About Calypso Biotech BV
Calypso Biotech BV is a private biotechnology company focused on the research and
development of novel biologics to address unmet medical need in immunological diseases, especially gastrointestinal indications. Calypso Biotech was established in 2013 as a spin-off by the healthcare business of Merck founded by Alain Vicari, Yolande Chvatchko and M Ventures, and is headquartered in Amsterdam, The Netherlands. Calypso is led by a team with strong experience and track record in translational immunology and the development of biologics, supported by an advisory board of clinical experts. For more information www.calypsobiotech.com

About Gilde Healthcare
Gilde Healthcare is a specialized European healthcare investor managing €1 billion ($1.2 billion) across two fund strategies: venture & growth capital and private equity. Gilde Healthcare’s venture & growth capital fund invests in health tech and therapeutics. The venture & growth companies are based in Europe and North America. Gilde Healthcare’s private equity fund invests in profitable European lower mid-market healthcare companies with a focus on the Benelux and DACH region. The private equity fund targets healthcare providers, suppliers of medical products and service providers in the healthcare market.
For more information www.gildehealthcare.com

Categories: News

Tags:

Semantix acquires translation provider Teknotrans

Segula

Through the acquisition of Teknotrans AB, Semantix continues its acquisition drive, strengthening its offering in the global market and consolidating its position as the Nordic language technology leader.

– Teknotrans’ business structure and customer base offer us great opportunities to strengthen Semantix’ offering in the global market. They also have a long history of delivering high-quality translations with a strong footprint in the automotive and industrial sector, which makes the acquisition interesting for us. The acquisition further consolidates Semantix’ role as the Nordic leader in language technology and multilingual services, says Patrik Attemark, Group CEO of Semantix.

Teknotrans was founded in 1971 and has offices in Gothenburg, Sweden, and in Split, Croatia. The company is fully owned by CEO, Christian Hammer.

– The acquisition comes at a perfect time for us to give Teknotrans a platform for continued growth, ensuring our customers access to broader and more complete language technology offerings, which is something Semantix will enable, says Christian Hammer, CEO of Teknotrans.

 

For more information please contact:
Patrik Attemark, Group CEO, patrik.attemark@semantix.se, +46 8 506 225 50

Categories: News

Tags:

Intertoys sold to Green Swan

Alteri

8th March 2019

 

  • New future for intertoys with Pan-European toy retailer Green Swan
  • Option to retain approximately 220 stores

Amsterdam, 8 March 2019.  Intertoys’ trustees Joris Lensink (De Vos & Partners lawyers) and Jasper Berkenbosch (Jones Day), and Alteri have jointly signed an agreement with Green Swan, a Portuguese toy retailing specialist, as a basis to realise a restart of part of the Dutch Intertoys business. The agreement opens the way to a restart for a substantial part of the retailer’s Dutch stores, and makes Intertoys part of the biggest toy retail group in continental Europe.

The trustees are pleased that Intertoys will retain its presence in the Dutch high street and that between 1,000 and 1,500 employees will keep their jobs. In addition, franchisees will have the opportunity to increase their number of stores. The trustees have therefore, in constructive cooperation with all stakeholders, achieved their initial goals.

This agreement combines the strength and expertise of the Netherlands’ market leader with an international strategic party in the toy sector. It is expected that Green Swan’s innovative mindset and expertise in streamlining stores and online business, will compensate for the inevitable reduction in the number of high street stores.

Paulo Andrez, CEO Green Swan: “We are enthusiastic to welcome Intertoys to the Green Swan family. We are highly motivated to bring our approach and strategic focus on innovation to the restart of a brand that so many families love. The toy sector is for families and people of all ages, and with Intertoys we see great potential to offer the customer an even better multichannel experience. We’ll partner with all those involved with Intertoys – clients, employees and franchisees – to add value through the innovation and evolution we’re bringing to the European toy market. Together with our toy brands in other European countries, such as Toys ‘R’ Us in Spain and Portugal and Maxi Toys in Belgium, France, Switzerland and Luxembourg, we are succeeding in revitalising a turbulent toy market.”

Following the bankruptcy of Intertoys on 21 February 2019, court-appointed trustees made efforts to secure a restart for Intertoys’ activities. This now led to the signing of an agreement with Green Swan.

The exact number of stores that will be included in the restart, and the number of employees involved, will become clear in the coming weeks. It is dependent, among other things, on whether lessors also want to maintain stores as Intertoys, accept compatible conditions and are aligned with the wishes of Green Swan and franchisees. Green Swan is to retain Intertoys current senior management, and aim to involve the franchisees in the restart.

91 Stores will be closed by the end of May at the latest. These stores will start with a closing down sale from Saturday, 9 March. A list of the relevant stores can be found on the website www.intertoys.nl as of tomorrow. Items purchased during this sale cannot be exchanged.

Further Information

The trustees will provide an update in a press release should there be any additional information or development of importance to report.

About Green Swan

Green Swan SGPS S.A. is a holding company, founded by “business angels” with extensive national and international experience in areas such as Management, Computer Engineering and new technologies, Marketing, Branding and Communication. Green Swan SGPS S.A. is driven by innovation and is dedicated to the acquisition or participation in viable and profitable companies, well managed but motivated to undertake innovation processes, continuing the wellbeing of its stakeholders. Green Swan has a strategic focus on the toy industry and is one of the most relevant players in the European market.

In August 2018, Green Swan acquired the Spanish and Portuguese operations of Toys “R” Us. And With the acquisition of Maxi Toys, in the beginning of 2019, Green Swan’s operations reach 6 European markets and a total of 230 stores. After this operation, Maxi Toys acquired all Bart Smit stores, achieving a presence in all Belgium territory.

For more Information (Not for Publication)

Green Swan: Rodrigo Saraiva; rodrigo.saraiva@ipsis.pt;

+351 910304766

Intertoys: David Brilleslijper

+31 20 255 9355

Categories: News

Tags:

EQT to sell majority stake in Direct ChassisLink to Funds Managed by Affiliates of Apollo Global Management

eqt

  • EQT Infrastructure to sell majority stake in DCLI, the largest marine and domestic chassis provider in North America, to funds managed by affiliates of Apollo Global Management, LLC
  • EQT Infrastructure to maintain a minority stake and will continue to support DCLI in solidifying its position as a leading asset provider in the North American intermodal market
  • During EQT Infrastructure’s ownership, DCLI has experienced substantial growth, strengthened its margins and expanded its digital supply chain platform

The EQT Infrastructure II and EQT Infrastructure III Funds (together “EQT Infrastructure” or “EQT”) today announced that they have entered into a definitive agreement to sell a majority stake in Direct ChassisLink, Inc. (“DCLI” or the “company”) to funds managed by affiliates of Apollo Global Management, LLC (“Apollo”). Under the terms of the agreement, EQT will retain a 20% minority stake.

Acquired by EQT in June 2016, DCLI is today a leading provider of marine and domestic chassis and asset management services in North America, operating an extensive network of approximately 235,000 chassis across over 450 locations. Chassis are an essential part of the transportation value chain and are used to carry containers between ships in port and local destinations, to and from intermodal hubs for long haul transport by rail or truck, and for last mile distribution.

Together with the management team, EQT has supported DCLI in executing on a business plan focused on accelerated growth. During EQT Infrastructure’s ownership, DCLI expanded into the domestic chassis market, acquiring nearly 90,000 domestic chassis supporting blue-chip customers through long-term agreements, and continued expansion within the marine chassis market. These transactions have not only nearly doubled the size of DCLI, but also diversified the company’s product offering and customer base. In addition, they have expanded DCLI’s national footprint to encompass all major ports and railway terminals in the US, positioning it as a leading chassis provider in the ever-growing North American market.

DCLI’s subsidiary, Blume Global, has developed its offering to include asset management, logistics execution, end-to-end supply chain visibility, optimization, automated financial settlement and more by leveraging nearly 25 years of data and customer insights. Since 1994, Blume Global has built a trusted platform in the global supply chain space with its integrated network and data insights across nearly 100 countries, more than 1,400 offices with 300+ IMCs, and 6,000+ motor carriers, and managing approximately 300,000 intermodal assets. Its platform processes USD 1 billion in transactions for customers with 99.99 percent billing accuracy.

Erwin Thompson, Partner at EQT Partners and Investment Advisor to EQT Infrastructure, commented: “DCLI has undergone a significant transformation and today is a leader in the North American intermodal market. Through DCLI’s expansion into the domestic chassis market and the transformation of Blume Global, the company has taken a leading position in providing a comprehensive suite of asset and supply chain services. DCLI has done a tremendous job expanding and executing on its strategy, and EQT is confident that Apollo will be a great partner as DCLI continues to build on its strong momentum. EQT Infrastructure is excited to maintain a minority stake in the company and looks forward to remaining a part of DCLI’s bright future.”

Bill Shea, CEO of DCLI, said: “With the support of EQT, DCLI has grown significantly, both in terms of our footprint in North America and our digital supply chain offering. We continue to build and deliver solutions that benefit participants across the global supply chain. Going forward, we are confident that, together with Apollo and EQT, we will continue to grow and strengthen the DCLI offering.”

The transaction is subject to customary conditions and approvals. It is expected to close in Q2 2019. Financial terms of the transaction were not disclosed.

Citigroup Global Markets Inc. acted as financial advisor and Simpson Thacher & Bartlett LLP as legal advisor to DCLI and EQT Infrastructure.

Contact
Erwin Thompson, Partner at EQT Partners, Investment Advisor to EQT Infrastructure, +1 917 281 0860
US inquiries: Stephanie Greengarten, +1 646 687 6810, stephanie.greengarten@eqtpartners.com
International inquiries: EQT Press Office, +46 8 506 55 334, press@eqtpartners.com

About EQT
EQT is a leading investment firm with more than EUR 50 billion in raised capital across 28 funds. EQT funds have portfolio companies in Europe, Asia and the US with total sales of more than EUR 19 billion and approximately 110,000 employees. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership. 

More info: www.eqtpartners.com

About DCLI
DCLI is the largest provider of marine and domestic container chassis and a leading provider of asset management services to the U.S. intermodal industry. The company owns, leases, and manages over 145,000 marine chassis and 89,000 domestic chassis. DCLI’s strategic partnership with Blume Global (formerly REZ-1), which began in 2014, uniquely positions the company to deliver value to its customers across the supply chain ecosystem via Blume’s digital supply chain platform. DCLI has a strong focus on safety and sustainability and is a participant in the U.S. Environmental Protection Agency’s (EPA) innovative WasteWise program.

More info: www.dcli.com

About Blume Global
From the world’s largest global retailers, manufacturers and consumer products companies to the smallest local drayage trucking companies, success depends on end-to-end visibility and orchestration of global supply chain networks across every move, every mode and every mile. With its AI-enabled, data-driven digital platform and solutions for real-time visibility, logistics execution, asset management, optimization and financial settlement, Blume Global leverages 25 years of data insights, its globally connected network, and advanced technologies to help enterprises be more agile and responsive, improve service delivery and reduce costs.

More info: www.blumeglobal.com

Categories: News

Tags:

Gilde Healthcare raises €200 million for new private equity fund

GIlde Healthcare

Targeting lower mid-market healthcare investments in the Benelux and DACH regions

Utrecht (the Netherlands) and Frankfurt (Germany) – Gilde Healthcare, the European specialist investor in healthcare, today announces that it has raised €200 million for its third private equity fund, Gilde Healthcare Services III. The fund will focus on healthcare providers, suppliers of medical products and service providers in the lower mid-market. The fund operates offices in Utrecht (The Netherlands) and Frankfurt (Germany).

The fund reached its hardcap in a few months’ time and was raised with Dutch institutional investors including, among others, PGGM/Pensioenfonds Zorg en Welzijn and Rabo Corporate Investments and various international fund-of-fund investors. To date, Gilde Healthcare has raised more than €1 billion for its dedicated healthcare investment funds. Examples of recent private equity investments include hospital software provider Performation, integrated telecom solutions provider Zetacom and drug discovery contract research organization MercachemSyncom.

Jasper van Gorp, Managing Partner at Gilde Healthcare: “We are pleased with the high level of interest for our new fund which is testament to our investment strategy and track record. We see a strong deal flow of healthcare providers, suppliers of medical products and service providers in the Benelux and DACH regions. Via our local presence we are well-positioned to source proprietary healthcare transactions in the lower mid-market.”

The new private equity fund is focused on established and profitable businesses in Europe with an EBITDA of between €2-15 million, preferably headquartered in the Benelux or DACH (Germany, Switzerland and Austria) regions.

In addition to capital, Gilde Healthcare provides hands-on support to the management of its portfolio companies, via activities such as implementing a growth strategy and leveraging its deep healthcare industry expertise and international network. Gilde Healthcare believes optimal value creation in healthcare is associated with better care at lower cost.

Recently, Gilde Healthcare strengthened its private equity team with additional experienced investment professionals: Rafael Natanek (previously a partner at Bain Consulting in the European healthcare practice) joined as partner and Boyd Rutten (previously at private equity firm EQT Partners) joined as senior associate.
About Gilde Healthcare

Gilde Healthcare is a specialized European healthcare investor managing €1 billion across two fund strategies: private equity and venture & growth capital. Gilde Healthcare’s private equity fund invests in profitable European lower mid-market healthcare companies including healthcare providers, suppliers of medical products and service providers, with a primary focus on the Benelux and DACH regions. Gilde Healthcare’s venture & growth fund is focused on fast growing health tech and therapeutics companies based in Europe and North America. https://gildehealthcare.com

Media Contacts

Gilde Healthcare

Jasper van Gorp
Managing Partner
Newtonlaan 91
3584BP Utrecht
The Netherlands
vangorp@gildehealthcare.com
+31 (0)30 219 2533

Dr Fabian Braemisch
Partner DACH-region
Neue Mainzer Strasse 74
60594 Frankfurt
Germany
braemisch@gildehealthcare.com
+49 69 153 255 870

CFF Communications

Jan van Ewijk
+31 (0)20 575 4011
+31 (0)6 14229820
jan.vanewijk@cffcommunications.nl

Aniek Zweers
+31 (0)20 575 4032
+31 (0)6 31973375
aniek.zweers@cffcommunications.nl

Categories: News

Tags:

CycloMedia Acquires Floating Point FX to Fuel US and International Growth

Volpi Capital

Acquisition Strengthens CycloMedia’s US Presence, Enhances Data Analytics Capabilities

Zaltbommel, Netherlands: 7 March 2019 – CycloMedia, the leading provider of accurate geospatial imagery-data and data analytics, announced today that it has acquired Floating Point FX, a 3D geospatial modelling company based in Madison, Wisconsin.

Floating Point FX (FPFX) provides powerful data visualisation and analytic platforms as a service within multiple geospatial industries. Utilising mobile LiDAR and imaging techniques, Floating Point FX produces highly detailed 3D visualisations of street-level environments. The company has been successfully delivering highly accurate data analytics solutions within the transportation, utilities & communications and public works markets. Increasingly, these workflow-enhancing solutions have been derived from CycloMedia’s highly accurate 3D imagery and LiDAR data.

Together, CycloMedia and Floating Point FX provide a wide range of imagery data analytics services, including LiDAR scanning, 3D modeling and 3D real-time scene capture, offering organisations complete solutions for their visualisation, design and analysis needs.

The acquisition allows CycloMedia to rapidly grow its presence in North America and to provide highly accurate data sets and street-level imagery across a wide variety of government and commercial markets. The deal will also enable future expansion into additional customer markets globally.

CycloMedia and Floating Point FX’s customers will benefit from the combined offering, which seamlessly delivers an accurate digital representation of the outside world to allow them to assess, analyse and measure physical infrastructures remotely.

“This is a strategic acquisition for CycloMedia that strengthens our team, builds our resources and expands our offering to accelerate our growth. Bolstering our US presence is an essential part of CycloMedia’s growth strategy worldwide,” said Joe Astroth, CEO US of CycloMedia.

“As the external world becomes increasingly complex, the integration of our two companies’ data and data analytics capabilities will help us meet our joint customers’ growing demand for a highly accurate, real-time digital representation of their environments. As part of this acquisition, we are exploring options to also introduce Floating Point’s technology in Europe.” said Frank Pauli, CEO of CycloMedia.

The deal follows significant equity investment in CycloMedia in August 2018 by Volpi Capital, a specialist European lower mid-market private equity firm. The Floating Point FX acquisition is part of CycloMedia’s data analytics investment strategy announced last year.

Crevan O’Grady from Volpi Capital added: “This is a landmark deal for CycloMedia. The addition of Floating Point FX gives CycloMedia an excellent platform in North America from which to capture the significant market opportunities, whilst also building upon its US success to date. This is also a proof of concept for the international buy and build strategy that Volpi and CycloMedia’s management have jointly set out in order to expand and grow the business over the medium term.”

Financial terms of the deal were not disclosed.

About CycloMedia

Founded in 1980, CycloMedia is the leading international provider of data and software solutions visualising the outside world accurately on-screen. CycloMedia’s customers derive actionable insights from the geodata platform to power day-to-day decisions remotely and with more accuracy, delivering exceptional ROI. CycloMedia focuses its solutions on tax assessment, asset management, public safety, construction & engineering, utility & transportation and insurance & real estate. CycloMedia employs 200 people and is based in Zaltbommel, the Netherlands, with operations in the US, Germany, and Scandinavia. For more information, please visit www.cyclomedia.com.

About Volpi Capital

Volpi Capital is a specialist European lower mid-market private equity firm. Volpi has a thesis-driven approach targeting ambitious businesses using enabling technologies to disrupt traditional B2B value chains. Volpi typically invests €25-75 million of equity in businesses with enterprise values between €50 million and €200 million and seeks to drive trans-formative growth through international expansion and consolidation. The firm, which was founded in 2016 by Crevan O’Grady and Marco Sodi, closed its first fund (Volpi Capital Fund I) in April 2018 with commitments of €185 million.

http://www.volpicapital.com

For all media enquiries, please contact:

Instinctif Partners

Ross Gillam/Justine Crestois

+44 20 7457 2020

volpi@instinctif.com

Categories: News

Tags: